Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.
about
Iranian-Islamic traditional medicine: An ancient comprehensive personalized medicineAdherence to antiepileptic drugs among children attending a tertiary health unit in a low resource setting.Increased 2-hydroxylation of estrogen is associated with lower body fat and increased lean body mass in postmenopausal women.Challenges and recommendations for conducting epidemiological studies in the field of epilepsy pharmacogeneticsGenetic polymorphism of drug refractory epilepsyTranslational research: Basic science to health care. Way forward.Synergistic association of STX1A and VAMP2 with cryptogenic epilepsy in North Indian population.Pharmacogenomics and epilepsy: the road ahead.The effect of ABCB1 genetic variants on chemotherapy response in HIV and cancer treatment.A hot topic: temperature sensitive sodium channelopathies.A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.The effect of genetic polymorphisms of cytochrome P450 CYP2C9, CYP2C19, and CYP2D6 on drug-resistant epilepsy in Turkish children.A thermoprotective role of the sodium channel β1 subunit is lost with the β1 (C121W) mutation.Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy.Case-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsy.
P2860
Q26775637-558A5B73-FDD5-43C0-BBC0-B5C4CDA5AE73Q33860089-C3B90235-FC21-4E37-972F-3FC6B8BF34E4Q35064178-EB4E6C66-4ACA-4C9A-ABD7-EEBE571E1079Q35073480-024B6132-15BE-4CC5-AA4A-877376125E97Q35351642-4287BC57-6C61-47D5-9082-D9B8AE653C60Q37046633-B6222866-4B6A-4A7A-A59E-E66BEC1724D7Q37110729-F15B74FA-5A91-47A8-BA45-30B82251C33DQ37946957-EADFB7CC-3CD2-4D96-869C-97AC6D80AC4CQ37946959-CADA1B54-D16A-460D-A265-E598A1ED03FDQ38014193-556E75CA-99D5-4184-907A-EC6AAC142B7BQ38090733-D03B3E41-56A9-4F97-A6B8-6388E662EDD6Q38651234-B76CD0CC-F695-42FD-9122-D2EAE4DAC9DAQ44649926-4C28AF23-3F2C-4E33-BB26-E7F6FDC267B2Q48682947-4F05FE14-0349-42C4-AB4F-7A374FA1F672Q51150804-43F5A2C8-E647-440D-96ED-B9FDD3D804E7Q54441071-C246032D-D257-479F-A449-C267A89358EF
P2860
Genetic profile of patients with epilepsy on first-line antiepileptic drugs and potential directions for personalized treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Genetic profile of patients wi ...... ns for personalized treatment.
@en
Genetic profile of patients wi ...... ns for personalized treatment.
@nl
type
label
Genetic profile of patients wi ...... ns for personalized treatment.
@en
Genetic profile of patients wi ...... ns for personalized treatment.
@nl
prefLabel
Genetic profile of patients wi ...... ns for personalized treatment.
@en
Genetic profile of patients wi ...... ns for personalized treatment.
@nl
P2093
P2860
P356
P1433
P1476
Genetic profile of patients wi ...... ns for personalized treatment.
@en
P2093
Abhay Sharma
Binuja Varma
Harpreet Kaur
Kavita Kaur
Kiran Bala
Krishnamoorthy Narayanasamy
Mandaville Gourie-Devi
Meena Gupta
Meenal Gupta
Puneet Talwar
P2860
P304
P356
10.2217/PGS.10.62
P577
2010-07-01T00:00:00Z